ADJIENE

Serial Number 97111099
Registration 7166840
700

Registration Progress

Application Filed
Nov 5, 2021
Under Examination
Approved for Publication
Jul 4, 2023
Published for Opposition
Jul 4, 2023
Registered
Sep 19, 2023

Trademark Image

ADJIENE

Basic Information

Serial Number
97111099
Registration Number
7166840
Filing Date
November 5, 2021
Registration Date
September 19, 2023
Published for Opposition
July 4, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 19, 2023
Registration
Registered
Classes
005

Rights Holder

SinoCellTech Ltd.

16
Address
Rm 301, 5 Bldg, No 31, Kechuang, 7th St
Beijing Economic-Tech Development Area
Beijing XXXXX
CN

Ownership History

SinoCellTech Ltd.

Original Applicant
16
Beijing CN

SinoCellTech Ltd.

Owner at Publication
16
Beijing CN

SinoCellTech Ltd.

Original Registrant
16
Beijing CN

Legal Representation

Attorney
Michael W. Piper

USPTO Deadlines

Next Deadline
1528 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-19)
Due Date
September 19, 2029
Grace Period Ends
March 19, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

17 events
Date Code Type Description
Sep 19, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 19, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 PUBO A PUBLISHED FOR OPPOSITION
Jul 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2023 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 25, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2023 ALIE A ASSIGNED TO LIE
May 15, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 18, 2022 GNRT F NON-FINAL ACTION E-MAILED
Aug 18, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2022 DOCK D ASSIGNED TO EXAMINER
Nov 16, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
vaccines; medicines for human purpose, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood products, namely, blood for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...